Chemotherapy-induced nausea and vomiting and patient characteristics in older adult cancer patients

These data were collected as part of a larger longitudinal study aiming to examine treatment effects of moderately- or highly-emetogenic chemotherapies among cancer patients at 24 hours and 5 days post-infusion. This anonymized dataset includes sociodemographic and clinical characteristics and both patient- and clinician-reported outcome measures of nausea and vomiting among 803 cancer patients.